Stainless Steel Construction From Tannroda

Stainless steel vessel solutions for industrial applications

Vessel & Equipment Construction

IRIS Solutions

Volume Measurement Vessels

Document Preservation

Custom Constructions

Services

We shape stainless steel

Stainless Steel Precision

We transform high-allow and corrosion-resistant steels into a large variety of products with utmost precision.
At its Tannroda site, Edelstahlbau Tannroda GmbH manufactures complex components in stainless steel for use in a wide range of industries.

Mobile test equipment for fuel dispenser testing with box body, operation from the rear of the vehicle
Extraction system
Reactor
Pipe components
Cyclone for collecting dust
Storage and transport tank
Process tank for sterile production
IRIS 2021 hardware
IRIS visualisation & software
Airports – test equipment volume standards 200 l, 2,000 l, 5,000 l
CIP tanks with insulating material
Pharmaceutical process tank pursuant to PED 2014/68/EU based on module A/A2/G.
Storage tank – single-walled
Stirring tank with angled turbine blade and protective grille
120l ATEX stirring tank with control cabinet
Sterile stirring tank with magnetic stirrer for small batch sizes
Leaf-casting machine for treating imperfections
Wet processing tanks as a 4-chamber system with heating and insulation jacket
Wet processing cassettes for absorbing book pages and documents
Stainless steel overflow pipettes
Draining basin on volume standard
Test equipment with horizontal volume standards 10 l, 20 l, 50 l, 100 l
Test equipment for liquid gas petrol pumps
Test equipment for bulk meters in ATEX
Mobile test equipment as a working standard
Mobile test equipment with box truck side operation
Process tank with hinged cover
Process tank with lifting system and Teflon coating for acid-based formulations
800 l sterile tank with load cells
Complex process system pursuant to ATEX 700
Sterile equipment with complete cladding

Successful customer project

Development, production and qualification of containers for vaccine production

We were able to make a significant contribution to this project in the context of vaccine production.
Please read the customer review and the press release of TÜV Thüringen.

IMG_6802
behaelterbau

Stirring and mixing solutions

Vessel & Equipment Construction

We develop, manufacture and inspect vessels and process systems for the manufacture, preparation and storage of your products, particularly in the pharmaceutical, food, cosmetics and chemical industries.

Solutions for the digital twin

Wireless Monitoring

An ideal addition to our mobile mixing and batching vessels is our wireless monitoring system IRIS. One of our most recent products, it is rapidly gaining users.

iris-monitoring
iris_edelstahlbau
volumenmesskoerper

Calibration solutions

Volume Measurement Vessels

Volumetric measurement devices to inspect the output for mineral oils, foodstuffs and liquid gas. As standard volume vessels or inspection equipment for mobile or stationary applications.

Solutions for historical documents

Document Preservation

Systems for paper treatment and book restoration.

We develop and manufacture systems for the treatment of historical texts, documents and paper and contribute to the work of restorers and archivers.

dokumentenerhalt
Verrohrungsschränke
sonderanfertigungen

Stainless steel solutions

Custom Constructions

We execute your custom designs, build prototypes and develop and manufacture test systems, individualised and tailored to your needs.

Sustainability solutions

Services

We are the right partner for maintenance, repair, qualification and modernisation of your existing vessels or systems.

service

Sehr geehrte Damen und Herren,
Sehr geehrter Herr Weinert,
27.04.2021


am 30. April 2021 eröffnen wir bei der Allergopharma GmbH & Co. KG in Reinbek einen weiteren Standort zur Unterstützung der COVID-19-lmpfstoffproduktion in Anwesenheit von Bundesminister Spahn und Ministerpräsident Günther. Zu dieser Eröffnung hätten wir Sie gerne eingeladen. 

Leider war dies pandemiebedingt nicht möglich.
Wir möchten uns daher auf diesem Weg für Ihr außergewöhnliches Engagement zur kurzfristigen Lieferung von Ausrüstungen zur Unterstützungd er Impfstoffproduktionb edanken. Die Allergopharma als Teil der Dermapharm Holding SE, ist nun ein weiterer Partner im europaweiten Produktionsnetzwerkes für den Impfstoff von BioNTech und Pfizer. Dieses umfasst mittlerweile mehr als ein Dutzend wichtige Pharmahersteller und Zulieferer. In Reinbek findet fortan einer von vier Herstellungsschritten statt: die Impfstoffformulierung. Hier wird unser mRNA-Wirkstoff mit den Lipiden verheiratet. Es entsteht eine schützende Hülle um das mRNA und der Impfstoff kann sein Ziel im Körper erreichen, um die notwendige Immunreaktion hervorzurufen.


Ihr Unternehmen hat mit großem Knowhow und unter unglaublichem Zeitdruck einen sehr wichtigen Beitrag zur globalen Pandemiebekämpfung geleistet. Dafür danken wir Ihnen und Ihrem Team herzlich! Ohne ihren Einsatz wäre der erfolgreiche Abschluss des Projekts nicht möglich gewesen.
Wir freuen uns, auch künftig partnerschaftlich mit Ihnen zusammenzuarbeiten!

Dr. Hans-Georg Feldmeier (CEO Dermapharm SE)
Dr. Sierk Poetting (CFO & COO BioNTech SE)

Dear Sir or Madam,
Dear Mr Weinert,
27.04.2021


On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.


Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE